Skip to main content
AstraZenecaPartnership

AstraZeneca invests SEK 30 million in obesity research at KI

Source: Autobound Signal API · 84 signals tracked for AstraZeneca · updated

Get AstraZeneca's live signals in Claude or ChatGPT, or by API

AskWhat changed at AstraZeneca this week? Use Autobound signals for astrazeneca.com.

What happened

AstraZeneca is investing over SEK 30 million in four research projects across a five-year initiative in collaboration with Karolinska Institutet and Karolinska University Hospital.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

AstraZeneca is investing just over SEK 30 million in four research projects in collaboration with Karolinska Institutet and Karolinska University Hospital. The initiative will run over the next five years and covers research into obesity, as well as kidney and liver diseases. The aim is to further strengthen Sweden's position as an international leader in life sciences. Karolinska Institutet, Karolinska University Hospital and AstraZeneca have an established, long-term partnership aimed at accelerating research and development in precision medicine in Sweden. AstraZeneca is now investing just over 30 million kronor to accelerate research into cardiometabolic and renal diseases. "Research of high scientific quality is crucial if we are to better understand complex diseases and develop the treatments of the future," says KI President Annika Östman Wernerson. "By bringing together academia, healthcare and industry, we are creating a strong environment for groundbreaking translational research." This expanded collaboration aims to yield innovative discoveries in several areas that can improve patients' health. One such area is obesity, and the obesity project represents a new field of research within the collaboration. By studying, amongst other things, the biological functions and significance of adipose tissue, the research aims to contribute to a deeper understanding of...

Keep reading with a free account

The rest of this article, and every signal for AstraZeneca, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

Location
Sweden

Companies

  • Karolinska InstitutetPartnerki.se

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Nov 16, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for AstraZeneca and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AstraZeneca this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/96a2d0f8-24f9-9a5b-5e62-32152ffd6237 returns this record as JSON. POST /v1/companies/enrich returns every signal for astrazeneca.com.

{
  "signal_id": "96a2d0f8-24f9-9a5b-5e62-32152ffd6237",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-11-16T17:02:23+00:00",
  "company": {
    "name": "AstraZeneca",
    "domain": "astrazeneca.com"
  },
  "data": {
    "url": "https://www.nationaltribune.com.au/astrazeneca-invests-sek-30-million-in-obesity-research-at-ki/",
    "title": "AstraZeneca invests SEK 30 million in obesity research at KI - The National Tribune",
    "excerpt": "AstraZeneca is investing just over SEK 30 million in four research projects in collaboration with Karolinska Institutet and Karolinska University Hospital. The initiative will run over the next five years and covers research into obesity, as well as kidney and liver diseases. The aim is to further strengthen Sweden’s position as an international leader in life sciences. Karolinska Institutet, Karolinska University Hospital and AstraZeneca have an established, long-term partnership aimed at accelerating research and development in precision medicine in Sweden. AstraZeneca is now investing just over 30 million kronor to accelerate research into cardiometabolic and renal diseases. “Research of high scientific quality is crucial if we are to better understand complex diseases and develop the treatments of the future,” says KI President Annika Östman Wernerson. “By bringing together academia, healthcare and industry, we are creating a strong environment for groundbreaking translational research.” This expanded collaboration aims to yield innovative discoveries in several areas that can improve patients’ health. One such area is obesity, and the obesity project represents a new field of research within the collaboration. By studying, amongst other things, the biological functions and significance of adipose tissue, the research aims to contribute to a deeper understanding of obesity...",
    "summary": "AstraZeneca is investing over SEK 30 million in four research projects across a five-year initiative in collaboration with Karolinska Institutet and Karolinska University Hospital.",
    "location": "Sweden",
    "planning": false,
    "image_url": "https://news.ki.se/sites/nyheter/files/qbank/GettyImages-1453942652_custom20261116170842.webp",
    "confidence": 0.95,
    "published_at": "2026-11-16T17:02:23Z",
    "location_data": [
      {
        "region": "Northern Europe",
        "country": "Sweden",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "AstraZeneca is investing just over SEK 30 million in four research projects in collaboration with Karolinska Institutet and Karolinska University Hospital.",
    "related_company_name": "Karolinska Institutet",
    "related_company_domain": "ki.se"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.